Compare · CODX vs MMM
CODX vs MMM
Side-by-side comparison of Co-Diagnostics Inc. (CODX) and 3M Company (MMM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CODX and MMM operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MMM is the larger of the two at $83.37B, about 6419.7x CODX ($13.0M).
- Over the past year, CODX is down 70.9% and MMM is up 4.3% - MMM leads by 75.2 points.
- MMM has been more active in the news (10 items in the past 4 weeks vs 5 for CODX).
- MMM has more recent analyst coverage (25 ratings vs 3 for CODX).
- Company
- Co-Diagnostics Inc.
- 3M Company
- Price
- $2.45-1.21%
- $159.81-1.19%
- Market cap
- $13.0M
- $83.37B
- 1M return
- -35.53%
- -1.05%
- 1Y return
- -70.94%
- +4.30%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NYSE
- IPO
- 2026
- News (4w)
- 5
- 10
- Recent ratings
- 3
- 25
Co-Diagnostics Inc.
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and liquid biopsy test for cancer screening. The company also provides tests that identify genetic traits in plant and animal genomes. In addition, it intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.
3M Company
3M Company develops, manufactures, and markets various products worldwide. It operates through four business segments: Safety and Industrial, Transportation and Electronics, Health Care, and Consumer. The Safety and Industrial segment offers personal safety products, industrial adhesives and tapes, abrasives, closure and masking systems, electrical markets, automotive aftermarket, and roofing granules to industrial, electrical, and safety markets. The Transportation and Electronics provides electronics, such as display materials and systems, electronic materials solutions; automotive and aerospace, and commercial solutions; advanced materials; and transportation safety products to transportation and electronic original equipment manufacturer customers. The Health Care segment offers medical and surgical supplies, skin health and infection prevention products, oral care, separation and purification sciences, health information systems, drug delivery systems, and food safety products to healthcare industry. The Consumer segment provides home improvement, home care, and consumer health care products, as well as stationery and office supplies to various consumers. This segment is also involved in the retail auto care business. It offers its products through various e-commerce and traditional wholesalers, retailers, jobbers, distributors, and dealers, as well as directly to users. 3M Company has a strategic collaboration with Merry Maids in residential cleaning sector; and collaborations with The Infectious Disease Research Institute and Duke Human Vaccine Institute to create a vaccine candidate with potential to provide protection against multiple variants of SARS-CoV-2. The company was founded in 1902 and is headquartered in St. Paul, Minnesota.
Latest CODX
- Co-Diagnostics Appoints Wes Lindsey, PhD, MBA as Chief Scientific Officer
- SEC Form PRE 14A filed by Co-Diagnostics Inc.
- Co-Diagnostics Invited to Participate in NPOC Tuberculosis Diagnostics Workshop in Bangkok, Thailand
- Co-Diagnostics Completes Clinical and Analytical Studies in Preparation for FDA 510(k) Submission of Upper Respiratory Point-of-Care Test
- Co-Diagnostics Vector Smart® Division Expands Footprint to 21 States
- Co-Diagnostics Hosts Kingdom of Saudi Arabia Joint Venture CoMira for Unveiling of Future Automated Manufacturing Line
- Co-Diagnostics Advances Latin American Commercialization Strategy for Co-Dx™ PCR Pro® with Mexico Distributor Agreement
- SEC Form SCHEDULE 13G filed by Co-Diagnostics Inc.
- Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform Capabilities
- SEC Form EFFECT filed by Co-Diagnostics Inc.
Latest MMM
- 3M upgraded by Analyst with a new price target
- 3M and Microsoft announce strategic partnership to advance AI data center infrastructure and enterprise transformation
- Scotch™ Brand launches Scotch Kids® Tape for young creators
- 3M Announces Upcoming Investor Event
- 3M Young Scientist Challenge Names 10 Finalists for 2026 National Competition
- Group President Bauer Wendy A exercised 7,952 shares at a strike of $159.96 and covered exercise/tax liability with 3,558 shares, increasing direct ownership by 94% to 9,086 units (SEC Form 4)
- 3M and Discovery Education announce 37 State Merit Winners and four Honorable Mentions in 2026 3M Young Scientist Challenge
- 3M joins Cadillac Formula 1® Team as Official Material Science Partner to accelerate racing performance
- 3M and Airbus announce agreement to advance A220 passenger comfort and aircraft performance through advanced insulation technology
- 3M launches Ask 3M, an AI-powered tool for faster access to technical expertise